M. Dræbye Gantzhorn

@MartinGantzhorn

Life Science & Healthcare, politics, law, sports - simple issues of life (personal tweets). Partner, IP | Life Science, Bech-Bruun

Copenhagen
Vrijeme pridruživanja: rujan 2013.

Tweetovi

Blokirali ste korisnika/cu @MartinGantzhorn

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MartinGantzhorn

  1. 4. velj

    Moderated today at Cambridge’s conference on global regulation and market access of highly regulated products, including pharmaceuticals, medicine devices, food and alcohol. Great teamwork, - thanks!

    Poništi
  2. 3. velj

    PHARMA DEBATE: The upcoming Council for Medical Devices and Healthtech - please do not repeat the flaws of the Danish Medicines Council!

    Poništi
  3. 3. velj

    LIFE SCIENCES: Reverse Payment Settlements European Court of Justice adopts very strict standard, which may threaten to limit the ability of the settling parties to defend such settlements by relying on the strength of the underlying patents and illustra…

    Poništi
  4. proslijedio/la je Tweet
    25. sij

    Dansk sprognævn vil erstattet “kære” med “hej” til både private og ikke-private modtagere. Nej tak. Jeg skal bede om at myndigheder og institutioner der skriver til mig skriver “kære”, mit fulde navn og er De’s. Jeg vil simpelthen ikke rages på mentalt i min privatsfære.

    Poništi
  5. 7. sij

    HOT TOPIC - MDCG Guidance on CYBERSECURITY for Medical Devices! According to the Guidance, manufacturers should foresee or evaluate the potential exploitation of cyber vulnerabilities that may be a result of “reasonably foreseeable misuse” and companies…

    Poništi
  6. PHARMA DEBATE: "Denmark's use of health data is controlled by fear - not opportunities." (in Danish, password required)

    Poništi
  7. “Med overvågning stiger friheden” - det sagde så vores allesammens JUSTITSminister!!! Lyt engang på ham - manden mener det faktisk ... Partier på tværs af ideologiske skel må sige klart fra overfor den selvbestaltede “logik”.

    Poništi
  8. Glimrende indlæg af blandt andet , , og ved dagens arrangement om det kommende behandlingsråd

    Poništi
  9. Great talk by re. the MDR and the IVDR at today’s DK Life Science Law event!

    Poništi
  10. Bech-Bruun assists Asahi Kasei in the Recommended Conditional Voluntary Public DKK 8.9 billion Offer for Veloxis Pharmaceuticals, Inc.

    Poništi
  11. EPO Guidelines 2019 - a continued overview of some of the updates to the EPO Guidelines for Examination

    Poništi
  12. MARKET ACCESS: The Danish Medicines Council introduces QALY and accepts reviewing data that has not been made publicly available. Unfortunately, the case handling time increases from 12 to 16 weeks.

    Poništi
  13. So excited to be moderating the Annual Danish LIFE SCIENCE AI & BIG DATA conference with excellent speakers, including (Dansk Erhverv), Dr. Manuela Maria Schöner (Boehringer Ingelheim), Peter Krusche (Novartis), (BenevolentAI)…

    Poništi
  14. proslijedio/la je Tweet
    11. stu 2019.

    I DK har vi nogle af de laveste medicinpriser i EU. Virksomheder konkurrerer hver 14. dag om den billigste pris. Du kan derfor opleve, at prisen på din medicin kan svinge en del på kort tid, både ⬆️og ⬇️, og derfor gives der tilskud til betaling

    Poništi
  15. Glæder mig meget til at debattere spændende og aktuelle emner med life science-eksperterne , Ida Sofie Jensen og Thomas Croft BucK.

    Poništi
  16. Have a look at our great General Counsel Programme 2020!

    Poništi
  17. Denmark joins New International Horizon Scanning Initiative to Track Innovative Medicines (IHSI) in addition to the European Integrated Price Information Database (Euripid). See the below response to the Danish Parliament's Health and Senior Citizens' C…

    Poništi
  18. Health Wearables & Big Data - The Danish Council on Ethics provides guidance on the use of data transitioning the Danish Healthcare System!

    Poništi
  19. New Q&A on Drug-Device-Combinations and MDR/IVDR impact is available.

    Poništi
  20. proslijedio/la je Tweet

    I dag er der høring om Medicinrådet, hvor evalueringen af rådet og eventuelle ændringer vil blive diskuteret. , , , og flere andre deltager. Se med live i dag 9.00-12.00:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·